Mesenchymal Stem Cell Therapy for Ischemic Tissues
Date
2018-10-08
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Ischemic diseases such as myocardial infarction, ischemic stroke, and critical limb ischemia are immense public health challenges. Current pharmacotherapy and surgical approaches are insufficient to completely heal ischemic diseases and are associated with a considerable risk of adverse effects. Alternatively, human mesenchymal stem cells (hMSCs) have been shown to exhibit immunomodulation, angiogenesis, and paracrine secretion of bioactive factors that can attenuate inflammation and promote tissue regeneration, making them a promising cell source for ischemic disease therapy. This review summarizes the pathogenesis of ischemic diseases, discusses the potential therapeutic effects and mechanisms of hMSCs for these diseases, and provides an overview of challenges of using hMSCs clinically for treating ischemic diseases.
Description
Keywords
Citation
Kar Wey Yong, Jane Ru Choi, Mehdi Mohammadi, Alim P. Mitha, Amir Sanati-Nezhad, and Arindom Sen, “Mesenchymal Stem Cell Therapy for Ischemic Tissues,” Stem Cells International, vol. 2018, Article ID 8179075, 11 pages, 2018. doi:10.1155/2018/8179075